Psychometric Validation and Meaningful Change Thresholds of the New Nasal Polyposis Symptom Diary.

Shih, Vivian H; Slagle, Ashley F; Ivanescu, Cristina; Flore, Giulio; Meyers, Oren; Kreindler, James; Martin, Ubaldo J; Werkström, Viktoria

Shih, Vivian H; Slagle, Ashley F; Ivanescu, Cristina; Flore, Giulio; Meyers, Oren; Kreindler, James; Martin, Ubaldo J; Werkström, Viktoria.

Afiliação

Shih VH; AstraZeneca, Gaithersburg, MD, USA.
Slagle AF; Aspen Consulting, LLC, Steamboat Springs, CO, USA.
Ivanescu C; IQVIA Real World Solutions, Patient Centered Solutions, New York, NY, USA.
Flore G; IQVIA Real World Solutions, Patient Centered Solutions, New York, NY, USA.
Meyers O; IQVIA Real World Solutions, Patient Centered Solutions, New York, NY, USA.
Kreindler J; AstraZeneca, Gaithersburg, MD, USA.
Martin UJ; AstraZeneca, Gaithersburg, MD, USA.
Werkström V; AstraZeneca, Gaithersburg, MD, USA.

Ann Otol Rhinol Laryngol ; 132(12): 1638-1648, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37271980

Palavras-chave

chronic rhinosinusitis with nasal polyposis; instrument development; meaningful change threshold; patient-reported outcome measure; psychometric properties

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Ann Otol Rhinol Laryngol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google